BociMed
Shanghai
About BociMed
BociMed is a company engaged in drug research and development and clinical research. Through the establishment of a standardized service system, it provides high-quality R&D and outsourcing services for drug discovery, preclinical pharmaceutical research and development, clinical I-IV trials and registration.Shanghai Bozhiyan New Drug Technology Co., Ltd. is a high-tech enterprise specializing in drug research and development technical services, Shanghai High-tech Enterprise, Shanghai Credit Creation Enterprise, and Shanghai Small and Medium Enterprise Innovation Undertaking Enterprise. The company started in 2007 and was formerly known as Shanghai Maibo Pharmaceutical Technology Co., Ltd., registered in Jinshan Petrochemical Zone, mainly engaged in raw material sales, drug import registration and regional cooperation development in China. In 2012,
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $14.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2023)
- Website: abc.bocimed.com
- Phone: 68861631, 68861632
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Information Technology
Canonical: https://fsome.com/organization/bocimed-33381 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.